http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014144404-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-025 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 |
| filingDate | 2013-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2014144404-A |
| titleOfInvention | IRON (III) -PYRAZINE-COMPLEX COMPOUNDS FOR TREATMENT AND PREVENTION OF PHENOMENA DEFICIENCY PHENOMENA IN THE BODY AND IRON-DEFICIENCY ANEMIA |
| abstract | 1. The complex compound iron (III) -pyrazin-2-ol-1-oxide or its pharmaceutically acceptable salts for use in the treatment and prevention of the phenomena of iron deficiency and iron deficiency anemia, as well as their accompanying symptoms. A complex compound of iron (III) for use according to claim 1, containing at least one ligand of the formula (I): where the arrows indicate the coordination bond with one or different iron atoms, R, R, R can be the same or different and are selected from a group consisting of: hydrogen, halogen, optionally substituted alkyl, optionally substituted alkoxyl, optionally substituted aryl, optionally substituted alkoxycarbonyl and optionally substituted aminocarbonyl, or R, R together with the carbon atoms to which they are bonded if necessary, form a substituted 5- or 6-membered saturated or unsaturated ring, which may optionally contain one or more heteroatoms, or pharmaceutically acceptable salts thereof. 3. A complex compound of iron (III) for use according to claim 2, containing at least one ligand of the formula (I): where the arrows indicate the coordination bond with one or different iron atoms, R, R, R can be the same or different, and selected from the group consisting of: hydrogen, optionally substituted alkyl, halogen, or R, R, together with the carbon atoms to which they are attached, form a 5- or 6-membered carbocyclic ring, or pharmaceutically acceptable salts thereof. 4. A complex compound of iron (III) for use according to claim 3, containing at least one ligand of the formula (I): where the arrows indicate the coordination bond with one or different iron atoms, R, R, R can be the same or different and select |
| priorityDate | 2012-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.